Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients

Citation
A. Carrascosa et al., Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients, J BONE MIN, 15(10), 2000, pp. 2005-2010
Citations number
39
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF BONE AND MINERAL RESEARCH
ISSN journal
08840431 → ACNP
Volume
15
Issue
10
Year of publication
2000
Pages
2005 - 2010
Database
ISI
SICI code
0884-0431(200010)15:10<2005:SBNIPP>2.0.ZU;2-3
Abstract
Lumbar L2-L4 bone mineral density (BMD) values were measured in 37 adolesce nt and young adult Turner syndrome patients. Nine had developed spontaneous puberty and had had regular menses since menarche (12.55 years +/- 1.17 ye ars) to the time of BMD evaluation (14.96 years +/- 1.26 years). In the oth er 28, puberty was induced with increasing doses of oral ethinyl estradiol (2.5-10.0 mu g/day, for 2 years) and later administration of estrogen/gesta gen therapy up to the time of BMD evaluation. In 18, the adolescent group, menarche appeared at 14.68 years +/- 0.63 years and BMD was evaluated at 17 .77 years +/- 0.70 years, and in the other 10, the young adult group, menar che appeared at 14.47 years +/- 0.53 years and BMD was evaluated at 20.90 y ears +/- 0.68 year. BMD values were in the normal range in those who had de veloped spontaneous puberty (Z score values, -0.24 +/- 0.22) and in the ost eopenia range in those in whom puberty was induced (Z score values, -2.09 /- 0.79 and -2.18 +\- 0.32 for the adolescent and young adult groups, respe ctively) p < 0.0001. Height Z score values were similar in all three groups (-3.45 +/- 0.77, -3.15 +/- 0.83, and -3.08 +/- 0.33, respectively), No sig nificant differences in calcium intake or physical activity were found amon g groups. Neither the karyotype distribution nor growth hormone (GH) therap y (five in the spontaneous puberty and six in the induced puberty groups ha d been treated for a 3.5- to 4.4-year period) explained the differences in BMD values. Because the main difference between groups was the availability of estrogens to bone tissue from infancy to menarche and of estrogens/gest agens from then on up to the time of BMD evaluation, our results suggest th at normal gonadal function from infancy to adulthood may be required for ad equate bone mass peaking. Early detection of osteopenia and improvement in general measures for adequate bone mass peaking (calcium intake and physica l activity) should be considered mandatory in the health care of these pati ents.